Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0SS6J
|
||||
Former ID |
DIB008864
|
||||
Drug Name |
GR-328713
|
||||
Synonyms |
GW-320449X; GW-328713X
|
||||
Indication | Arteriosclerosis [ICD9: 440; ICD10:I70] | Discontinued in Phase 1 | [546541] | ||
Company |
Glaxo Wellcome plc
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
N12[C@@H](C(=O)N(CC1=O)C1CCCC1)Cc1c(C2)c(c(OCc2ncccc2)c<br />c1)CC=C
|
||||
CAS Number |
CAS 206201-12-9
|
||||
Target and Pathway | |||||
Target(s) | Microsomal triglyceride transfer protein, large subunit | Target Info | Modulator | [550856] | |
KEGG Pathway | Fat digestion and absorption | ||||
Reactome | Chylomicron-mediated lipid transport | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.